Urogen Pharma (URGN)
NASDAQ:URGN
Holding URGN?
Track your performance easily

Urogen Pharma (URGN) Income Statement

437 Followers

Urogen Pharma Income Statement

Last quarter (Q2 2024), Urogen Pharma's total revenue was $21.85M, an increase of 3.35% from the same quarter last year. In Q2, Urogen Pharma's net income was $-33.40M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 85.01M$ 82.71M$ 64.36M$ 48.04M$ 11.80M$ 18.00K
Cost of Revenue
$ 8.61M$ 9.36M$ 7.65M$ 5.16M$ 1.01M$ 0.00
Gross Profit
$ 76.40M$ 73.35M$ 56.70M$ 42.88M$ 10.79M$ 18.00K
Operating Expense
$ 153.65M$ 138.89M$ 135.74M$ 135.18M$ 137.53M$ 109.50M
Operating Income
$ -79.69M$ -65.54M$ -79.04M$ -92.29M$ -126.74M$ -109.48M
Net Non Operating Interest Income Expense
$ -13.31M$ -14.71M$ -7.43M$ 212.00K$ 1.63M$ 4.33M
Other Income Expense
$ -656.00K$ -838.00K$ -72.00K$ -212.00K-$ -284.00K
Pretax Income
$ -109.65M$ -98.32M$ -108.03M$ -109.37M$ -125.11M$ -105.15M
Tax Provision
$ 3.94M$ 3.92M$ 1.75M$ 1.45M$ 3.37M$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -113.58M$ -102.24M$ -88.22M$ -110.82M$ -128.48M$ -105.15M
Basic EPS
$ -3.10$ -3.55$ -4.81$ -4.96$ -5.90$ -5.12
Diluted EPS
$ -3.10$ -3.55$ -4.81$ 0.00$ -5.90$ -5.12
Basic Average Shares
$ 138.80M$ 28.83M$ 22.81M$ 22.35M$ 21.78M$ 20.53M
Diluted Average Shares
$ 138.80M$ 28.83M$ 22.81M$ 22.35M$ 21.78M$ 20.53M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 162.26M$ 148.25M$ 143.40M$ 140.33M$ 138.54M$ 109.50M
Net Income From Continuing And Discontinued Operation
$ -113.58M$ -102.24M$ -109.78M$ -110.82M$ -128.48M$ -105.15M
Normalized Income
$ -74.88M$ -77.68M$ -77.69M-$ -128.48M$ -105.15M
Interest Expense
------
EBIT
$ -92.37M$ -65.54M$ -99.59M$ -92.08M$ -126.74M$ -109.48M
EBITDA
$ -90.63M$ -63.85M$ -96.52M$ -89.83M$ -124.69M$ -108.15M
Currency in USD

Urogen Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis